Fluvastatin exposure during pregnancy

Obstetrics and Gynecology

Volumn 93, Issue 5 SUPPL., 1999, Pages 847-

  Seguin, John ^a   Samuels, Philip ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDOSTATIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; ARTICLE; CASE REPORT; CONCEPTION; DRUG EFFECT; DRUG EXCRETION; DRUG PROTEIN BINDING; FEMALE; HUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ADULT; ANTICHOLESTEREMIC AGENTS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYPERLIPIDEMIAS; INDOLES; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0344417169     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00572-9     Document Type: Article

References (4)

1. Garnett W.R. A review of current clinical findings with fluvastatin. Am J Cardiol. 78:(suppl 6A):1996;20-25.
2. Hrab R.V., Hartman H.A., Cox R.H. Jr. Prevention of fluvastatin-induced toxicity, mortality, and cardiac myopathy in pregnant rats by mevalonic acid supplementation. Teratology. 50:1994;19-26.
3. Frankenberg W.K., Dodds J., Archer P., Shapiro H., Bresnick B. The Denver II A major revision and restandardization of the Denver Developmental Screening Test . Pediatrics. 89:1992;91-97.
4. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation. 5th ed. 1998;630-632 Williams & Wilkins, Baltimore, Maryland.